Bivalirudin, a peptide anticoagulant, is a direct thrombin inhibitor for anticoagulation in the setting of invasive cardiology, particularly percutaneous coronary intervention.
性状
Solid
体内研究(In Vivo)
Bivalirudin (2 mg/kg) delays both the time for appearance of first thrombus and the time for occlusion in P2Y12 arteries, although neither prevented vessel occlusion.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.